Cardiovascular Health Topics
The On-Topic Netowork

Cardiovascular Health > Heart Attack, Or Myocardial Infarction (MI)

The following information is about Heart Attack, Or Myocardial Infarction (MI).

Heart Attack, Or Myocardial Infarction (MI) Defined

An event which occurs when an area of the heart muscle is damaged or has died as a result of insufficient blood and oxygen reaching that part of the heart (Read more)

This definition is in context to Cardiovascular Health. See more contextual defintions for Heart Attack, Or Myocardial Infarction (MI).


Navigation: [ 1 2 Next ]

Early Emergency Call May Have Saved Life

Published September 3, 2008, 7:40 am, Westport News

For many people, a bloated, gassy feeling is something that would warrant reaching for the antacids in the medicine cabinet rather than for the phone to call an ambulance.

Full Story


PRASUGREL SIGNIFICANTLY REDUCED NEW OR RECURRENT HEART ATTACKS IN BOTH ACUTE AND LONGER-TERM SETTINGS FOLLOWING PCI, ...

Published September 3, 2008, 12:48 am, Bernama via Yahoo! Malaysia News

ATTENTION EDITOR, GENERAL DESK

Full Story


Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, ...

Published September 3, 2008, 12:47 am, Thaipr.net

A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment with prasugrel compared with clopidogrel significantly reduced the risk of new or recurrent heart attacks (7.4 percent vs. 9.7

Full Story


Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, ...

Published September 3, 2008, 12:16 am, PR Newswire via Yahoo! Finance

A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment with prasugrel compared with clopidogrel significantly reduced the risk of new or recurrent heart attacks , regardless of whether the events occurred around the time of an artery-opening procedure known as percutaneous coronary intervention , or if they occurred spontaneously during the longer-term maintenance phase.

Full Story


*vwd/BUSINESS WIRE: New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome ...

Published September 2, 2008, 2:14 am, vwd.de

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.

Full Story


New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients

Published September 2, 2008, 2:00 am, Business Wire via Yahoo! Finance

PRINCETON, N.J. & NEW YORK----Bristol-Myers Squibb Company and Pfizer Inc announced today the results of a Phase 2 dose-ranging study involving the investigational compound apixaban in patients with acute coronary syndrome .

Full Story


Acute Heart Attack Patients Given AGGRASTAT(R) In-Ambulance, With Standard Of Care, Significantly Improves Clinical ...

Published September 1, 2008, 5:09 am, Medical News Today

Early, in-ambulance treatment with antiplatelet medicine AGGRASTAT® (tirofiban HCL), in addition to the standard combined treatment of aspirin, heparin and clopidogrel, significantly improves the results of primary coronary angioplasty (PCI) in patients with ST-elevated myocardial infarction (STEMI).

Full Story


With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial ...

Published August 31, 2008, 8:02 pm, Thaipr.net

Press conference The BEAUTIFUL study: a step further in title Coronary Artery Disease ESC Hotline Title: The BEAUTIFUL study: efficacy of session title ivabradine in reduction of cardiovasc

Full Story


Treatment Appears To Reduce Heart Attack Risk And Revascularisation In Stable Coronary Patients

Published August 31, 2008, 7:21 pm, Science Daily

Ivabradine is the first antianginal treatment shown to reduce myocardial infarction and revascularisation and to have a good tolerability profile even when used with other drugs.

Full Story


The BEAUTIFUL study: Ivabradine and the reduction of cardiovascular events

Published August 31, 2008, 4:10 am, News-Medical-Net

The results of the much awaited BEAUTIFUL (morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with CAD and left ventricULar dysfunction) trial have shown that coronary artery disease (CAD) patients with left ventricular dysfunction (LVD) and a heart rate more than 70 bpm have a significantly higher risk of cardiovascular death and other cardiovascular events and in these ...

Full Story


Navigation: [ 1 2 Next ]

Are you looking for additional Cardiovascular Health > Heart Attack, Or Myocardial Infarction (mi) news? Try our new "Heart Attack, Or Myocardial Infarction (mi) News Focus" area.

Social bookmarks are not available at the moment.

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Heart Attack, Or Myocardial Infarction (MI). If you would like to find related tags we recommend Tag Patterns > Heart Attack, Or Myocardial Infarction (MI)

Off-site Heart Attack, Or Myocardial Infarction (mi) Research Links

If you still need additional information on Heart Attack, Or Myocardial Infarction (mi) then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Cardiovascular Health

If you know the Cardiovascular Health Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Cardiovascular-Health.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a